Policy

• 

  From the Editor-in-Chief

  Measuring a Cancer Drug’s Effectiveness

  Surrogate endpoints can speed up drug approvals, but are they valid measures of effectiveness?

  by William G. Nelson, MD, PhD

• 

  Forward Look

  Here Come the Biosimilars

  As patents expire on biologic drugs, cancer patients get new options.

  by Stephen Ornes

• 

  In It for the Long Haul

  Doctors and researchers met online to discuss how the coronavirus pandemic changed cancer care in its early months, as well as how they can improve care and advocate for patients going forward.

  by Kate Yandell

• 

  The Return to Work

  What happens if your workplace reopens before you're ready to return or you're an essential worker? For some people who have been diagnosed with cancer, accommodations may be possible.

  by Jen Tota McGivney

• 

  Policy Matters

  Racial and Ethnic Disparities in Multiple Myeloma Clinical Trials

  The AACR and the FDA presented joint recommendations that include broadening clinical trial eligibility and engaging the community in clinical trial recruitment.

  by Kenneth C. Anderson, MD; Lola A. Fashoyin-Aje, MD, MPH; Nicole Gormley, MD; and Paul G. Kluetz, MD

• 

  Survivor Profile

  Sharing Her Strength

  Diagnosed with two cancers prior to turning 40, Rebecca Esparza uses her voice to advocate for policy changes to help people affected by cancer.

  by Lindsey Konkel

• 

  Robotic Surgery and Cancer

  Using robotic assistants for cancer surgery has become commonplace. Whether cancer patients benefit when a surgeon uses a robot remains unclear.

  by Sue Rochman

• 

  Pushing Progress Forward

  NCI Director Norman E. “Ned” Sharpless addresses disparities and maps out plans for the future amid “profound upheaval.”

  by Kevin McLaughlin

• 

  Forward Look

  Makers of E-Cigarettes Tout Role in Smoking Cessation

  Studies provide little evidence to support this claim.

  by Stephen Ornes

• 

  Cancer Care Moves Forward Amid COVID-19

  Following the arrival of the coronavirus in the U.S., people with cancer and their doctors are adjusting to new ways of doing things while continuing to seek and provide cancer care.

  by Kate Yandell